Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
356 open access dissertations and theses found for:
if(Immunotherapy)  »   Refine Search
1.
Amyloid -beta immunotherapy as a treatment and diagnostic modality in Alzheimer's disease
by Tucker, Stina M. Fangmark, Ph.D.  The Johns Hopkins University. 2008: 189 pages; 3311848.
2.
Immunotherapy targeting tau pathology-studies in an hTau mouse model
by Forest, Stefanie Karen, Ph.D.  Yeshiva University. 2014: 153 pages; 3535073.
3.
Defining Factors that Determine Effective Anti-Melanoma Tumor Immunity
by Thakral, Durga, Ph.D.  Yale University. 2019: 212 pages; 13806784.
4.
Tau-Directed Immunotherapy for Alzheimer's Disease
by Schroeder, Sulana K., Ph.D.  University of South Florida. 2017: 205 pages; 10264596.
5.
Natural Killer T Cell Development and Activation: Implications in Cancer Immunotherapy
by Shissler, Susannah Claire, Ph.D.  University of Maryland, Baltimore. 2019: 181 pages; 27540862.
6.
Immunotherapy and T cell receptor analysis in recurrent type 1 diabetes
by Garland, Alaina Leigh, Ph.D.  The University of North Carolina at Chapel Hill. 2012: 136 pages; 3509265.
7.
Combination immunotherapy for early and continuous protection from methamphetamine pharmacological effects
by Hambuchen, Michael D., Ph.D.  University of Arkansas for Medical Sciences. 2013: 168 pages; 3610333.
8.
MHC II cell based immunotherapy for non-small cell lung cancer in the presence of immune suppression
by Srivastava, Minu Kumari, Ph.D.  University of Maryland, Baltimore County. 2009: 240 pages; 3371813.
9.
Preclinical Development of an Immunotherapy against Antibiotic-Resistant Staphylococcus aureus
by Oesterreich, Babett, Ph.D.  Bayerische Julius-Maximilians-Universitaet Wuerzburg (Germany). 2015: 151 pages; 27766761.
13.
Androgen Receptor and Vitamin D Signaling in Bladder Cancer
by Hsu, Jong-Wei, Ph.D.  University of Rochester. 2011: 119 pages; 3498248.
15.
In vivo mechanisms leading to reduced function of anti-methamphetamine monoclonal antibodies
by Atchley, William Thomas, Ph.D.  University of Arkansas for Medical Sciences. 2013: 172 pages; 3563470.
17.
Mathematical models of tumor growth and therapy
by Robertson-Tessi, Mark, Ph.D.  The University of Arizona. 2010: 217 pages; 3412173.
18.
E-Cadherin Enhances Immune Control of Metastatic Melanoma
by Shields, Bradley Douglas, Ph.D.  University of Arkansas for Medical Sciences. 2018: 183 pages; 10787641.
19.
Antigen-specific immune modulation using an injectable biomaterial
by Verbeke, Catia Stephanie, Ph.D.  Harvard University. 2014: 168 pages; 3627259.
20.
21.
22.
T Cell Immunity in Acute Myeloid Leukemia Patients After Chemotherapy and During Immune Checkpoint Inhibition
by Goswami, Meghali, Ph.D.  The George Washington University. 2020: 196 pages; 27743062.
23.
Controlled delivery of a glutamate receptor modulator to promote regulatory T cells and restrain autoimmunity
by Gammon, Joshua Marvin, M.S.  University of Maryland, College Park. 2015: 62 pages; 10012602.
24.
Understanding cell-mediated immunity against human papillomavirus-related diseases: Common warts and cervical disease
by Kim, Kevin Hyungwoo, Ph.D.  University of Arkansas for Medical Sciences. 2010: 142 pages; 3443402.
26.
27.
Lymphocyte responses to the polyphenol, oenothein B, and the influence of age on these responses
by Ramstead, Andrew Gordon, Ph.D.  Montana State University. 2014: 183 pages; 3630555.
28.
Development of a Recombinant Attenuated Salmonella Cancer Vaccine
by Hand, Nicholas, Ph.D.  The George Washington University. 2018: 202 pages; 10635177.
29.
1 - 30 of 356 displayed.
  1    2    3    4    5    6    7    8    9    10   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest